Tema Heart & Health ETF HRTS

Morningstar Medalist Rating

Morningstar’s Analysis HRTS

Will HRTS outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Tema Heart & Health ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HRTS

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings46.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

12.747M
Healthcare

Thermo Fisher Scientific Inc

5.283M
Healthcare

Roche Holding AG ADR

4.383M
Healthcare

Merck & Co Inc

4.142M
Healthcare

Kodiak Sciences Inc

3.792M
Healthcare

BridgeBio Pharma Inc

3.672M
Healthcare

Gilead Sciences Inc

3.402M
Healthcare

UnitedHealth Group Inc

3.142M
Healthcare

Revolution Medicines Inc Ordinary Shares

3.102M
Healthcare

Danaher Corp

3.092M
Healthcare

Sponsor Center